Aura Biosciences earnings were -$112.4M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest AURA earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$33.7M, up 31.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AURA reported annual earnings of -$106.2M, with 22.2% growth. The next AURA earnings date is Aug 12, 2026.
What were Aura Biosciences's earnings last quarter?
On AURA's earnings call on May 7, 2026, Aura Biosciences (NASDAQ: AURA) reported Q1 2026 earnings per share (EPS) of -$0.50, up 9.09% year over year. Total AURA earnings for the quarter were -$33.69 million. In the same quarter last year, Aura Biosciences's earnings per share (EPS) was -$0.55.
The next AURA earnings date is Aug 12, 2026. Add AURA to your watchlist to be reminded of Aura Biosciences's next earnings date.
Is Aura Biosciences profitable or losing money?
As of the last Aura Biosciences earnings report, Aura Biosciences is currently losing money. Aura Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$112.39 million, a 18.69% increase year over year.
What was AURA's earnings growth in the past year?
As of Aura Biosciences's earnings date in May 7, 2026, Aura Biosciences's earnings has grown year over year. AURA earnings in the past year totalled -$112.39 million.
What are Aura Biosciences's earnings expectations?
The current EPS estimate for Aura Biosciences's earnings report in Aug 12, 2026 is -$0.41.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.